Cereno Scientific Balance Sheet Health
Financial Health criteria checks 6/6
Cereno Scientific has a total shareholder equity of SEK216.4M and total debt of SEK45.4M, which brings its debt-to-equity ratio to 21%. Its total assets and total liabilities are SEK285.0M and SEK68.6M respectively.
Key information
21.0%
Debt to equity ratio
kr45.40m
Debt
Interest coverage ratio | n/a |
Cash | kr87.17m |
Equity | kr216.42m |
Total liabilities | kr68.56m |
Total assets | kr284.99m |
Financial Position Analysis
Short Term Liabilities: CRNO B's short term assets (SEK88.7M) exceed its short term liabilities (SEK23.2M).
Long Term Liabilities: CRNO B's short term assets (SEK88.7M) exceed its long term liabilities (SEK45.4M).
Debt to Equity History and Analysis
Debt Level: CRNO B has more cash than its total debt.
Reducing Debt: CRNO B's debt to equity ratio has reduced from 42.5% to 21% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CRNO B has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CRNO B has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 37% each year.